1. Home
  2. MTZ vs BIO Comparison

MTZ vs BIO Comparison

Compare MTZ & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasTec Inc.

MTZ

MasTec Inc.

HOLD

Current Price

$223.50

Market Cap

17.4B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$301.75

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTZ
BIO
Founded
1929
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
17.4B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MTZ
BIO
Price
$223.50
$301.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
4
Target Price
$231.37
$358.50
AVG Volume (30 Days)
817.9K
161.8K
Earning Date
10-30-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
270.77
N/A
EPS
4.20
N/A
Revenue
$13,762,473,000.00
$2,557,500,000.00
Revenue This Year
$15.48
$1.77
Revenue Next Year
$10.21
$2.30
P/E Ratio
$53.60
N/A
Revenue Growth
12.99
N/A
52 Week Low
$99.70
$211.43
52 Week High
$233.14
$373.69

Technical Indicators

Market Signals
Indicator
MTZ
BIO
Relative Strength Index (RSI) 58.21 42.26
Support Level $206.15 $295.01
Resistance Level $227.08 $307.07
Average True Range (ATR) 7.95 8.09
MACD -0.09 -1.25
Stochastic Oscillator 64.28 22.23

Price Performance

Historical Comparison
MTZ
BIO

About MTZ MasTec Inc.

MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: